2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Mini-Oral Session

[MO33] Mini-Oral Session 33 COVID-19 2

Sat. Feb 19, 2022 3:40 PM - 4:30 PM Room 4 (Room A, 2F, Kyoto International Conference Center)

Chair:Eiki Ichihara(Department of Allergy and Respiratory Medicine, Okayama University),Taiji Koyama(Department of Medical Oncology/Hematology, Kobe University)

[MO33-1] Limited Increase in Antibody Titers following BNT162b2 for More than 3 Years after Final Dose of Anti-CD20 Antibody

Yohei Funakoshi1, Kimikazu Yakushijin1, Goh Ohji2, Wataru Hojo3, Hironori Sakai3, Marika Watanabe1, Sakuya Matsumoto1, Yu Mizutani1, Akihito Kitao1, Yoshiharu Miyata4, Yasuyuki Saito5, Shinichiro Kawamoto6, Katsuya Yamamoto1, Mitsuhiro Ito7, Meiko Nishimura1, Yoshinori Imamura1, Naomi Kiyota1,8, Hiroshi Matsuoka4, Yasuko Mori9, Hironobu Minami1,8 (1.Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, 2.Division of Infection Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Hospital and Graduate School of Medicine, 3.R&D, Cellspect Co., Ltd., 4.BioResource Center, Kobe University Hospital, 5.Division of Molecular and Cellular Signaling, Kobe University Graduate School of Medicine, 6.Department of Transfusion Medicine and Cell Therapy, Kobe University Hospital, 7.Division of Medical Biophysics, Kobe University Graduate School of Health Sciences, 8.Cancer Center, Kobe University Hospital, 9.Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password